Back

Etripamil - a multichannel modulator to suppress atrial fibrillation

30 March 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Basic science and arrhythmias (1) Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Merten Prueser

University of Heidelberg, Heidelberg (Germany)

4 More presentations in this session

Presentation thumbnail
Telomere length is associated with adverse atrial remodeling in patients with atrial fibrillation
Professor M. Gramlich (Aachen, DE)
Abstract Slides Video
Presentation thumbnail
Histological validation of clinical classification models of atrial cardiomyopathy
Doctor J. Winters (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Transmurality of post-myocardial infarction scar and the cycle length of ventricular tachycardia
Doctor M. Freeman (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Acute in vivo antiarrhythmic effects of cGMP-modifying drugs in the R2474S mouse model of catecholiminergic polymorphic ventricular tachycardia.
Doctor P. Tickle (Manchester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Basic science and arrhythmias (1)

The Event

Event poster

EHRA 2025

30 March 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
New AADs: what's in the pipeline?
thumbnail
Congress Presentation
Promising electrical targets for novel antiarrhythmic strategies in atrial fibrillation
thumbnail
Congress Presentation
New targeted antiarrhythmic drugs

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources